Cargando…
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients
Tumour-infiltrating lymphocytes (TILs) are considered to have prognostic and predictive value for patients with early breast cancer. We examined 1166 breast cancer patients from a prospective, multicentre cohort (Prognostic Assessment in Routine Application (PiA), n = 1270, NCT 01592825) following r...
Autores principales: | Schüler, Kathleen, Bethmann, Daniel, Kaufhold, Sandy, Hartung, Carolin, Stückrath, Kathrin, Lantzsch, Tilmann, Uleer, Christoph, Hanf, Volker, Peschel, Susanne, John, Jutta, Pöhler, Marleen, Buchmann, Jörg, Bürrig, Karl-Friedrich, Weigert, Edith, Thomssen, Christoph, Kantelhardt, Eva Johanna, Vetter, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601161/ https://www.ncbi.nlm.nih.gov/pubmed/36292215 http://dx.doi.org/10.3390/diagnostics12102527 |
Ejemplares similares
-
PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022) -
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
por: Bernhardt, Stephan, et al.
Publicado: (2017) -
Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients
por: Bauer, Marcus, et al.
Publicado: (2019) -
Association of caspase 8 polymorphisms -652 6N InsDel and Asp302His with progression-free survival and tumor infiltrating lymphocytes in early breast cancer
por: Kuhlmann, Jan Dominik, et al.
Publicado: (2019) -
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel
por: Kantelhardt, Eva J, et al.
Publicado: (2011)